VDA-1102 : A Novel Well-Tolerated Treatment For Actinic Keratosis

2018

Abstract not available. Disclosures: Study sponsored by Vidac Pharma. Copyright 2018 SKIN

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

0

References

1

Citations